Metanephric glomerular mesangium development

pathway activity — cross-omics
GO:0072223Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Metanephric glomerular mesangium development pathway is significantly associated with the RNA expression of multiple genes, with the CCRCC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are RBP7, CPA3, and PECAM1, each associated with the pathway in up to 6 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Metanephric glomerular mesangium development activity versus RBP7 in CCRCC (Pearson r = 0.38).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
CCRCCRBP7 →+0.903+0.324.002.00434
CCRCCCPA3 →+0.954+0.325.003.00534
COADPECAM1 →+0.818+0.903<.001.00834
CCRCCPLPP1 →+0.636+0.218.001.00534
UCECRAD54B →-0.397-0.576.004.00934
COADCD36 →+0.909+0.874<.001.00134
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0072223 vs RBP7 — CCRCC

Per-sample scatter of Metanephric glomerular mesangium development activity vs RBP7 in CCRCC.

Explore this scatter interactively →

Exploration